Table 3.
Quetiapine doses in the XR and IR groups during hospitalisation and at discharge
| Quetiapine dose (mg) | Patients treated with quetiapine XR or IR during hospitalisation (%) |
Patients treated with quetiapine XR or IR at discharge (%) |
Patients discharged with quetiapine XR or IR as the only antipsychotic (%) |
|||
| XR (n=43) | IR (n=58) | XR (n=43) | IR (n=58) | XR (n=26) | IR (n=15) | |
| ≤200 | 2.3 | 48.3 | 2.3 | 24.1 | 3.9 | 60.0 |
| 201–400 | 32.6 | 12.1 | 16.3 | 6.9 | 15.4 | 0 |
| 401–600 | 23.3 | 17.2 | 4.7 | 12.1 | 7.7 | 13.3 |
| 601–1000 | 32.6 | 19.0 | 41.9 | 12.1 | 53.9 | 20.0 |
| ≥1000 | 9.3 | 3.4 | 11.6 | 3.4 | 19.2 | 6.7 |
| Not discharged with study drug | – | – | 23.3 | 41.4 | – | – |
IR, immediate release; XR, extended release.